局部晚期胰腺癌的消融放疗:技术与结果
常规分割放疗标准剂量对不可切除局部晚期胰腺癌(LAPC)患者生存影响甚微。低剂量立体定向体部放疗(SBRT)3–5次分割可小幅改善中位生存且毒性低、疗程短,但2年及以后无显著差异。实现肿瘤消融可能需要更高的生物有效剂量(BED),难点在于邻近高度敏感的胃肠道处给予消融剂量。先进器官运动管理、图像引导和自适应计划技术使得使用更长的低分割方案或先进图像引导与自适应计划时能够给予消融剂量(>=100Gy BED),多项研究显示生存获益令人鼓舞。本综述总结放疗技术从常规到消融的演变,并描述利用锥形束CT(CBCT)引导和在线自适应MRI引导在胃肠道附近实施消融剂量的实践方面。
要点
- 常规分割标准剂量放疗对LAPC生存影响甚微。
- 低剂量SBRT(3–5次)仅小幅改善中位生存,2年及以后无显著差异。
- 消融剂量(>=100Gy BED)需先进运动管理、图像引导和自适应计划。
核心结论
- 常规分割标准剂量放疗对LAPC患者生存影响甚微,低剂量SBRT仅小幅改善中位生存但2年及以后无显著差异。
- 实现肿瘤消融可能需要更高BED,先进技术可在胃肠道附近安全给予消融剂量(>=100Gy BED)并显示生存获益。
研究设计与样本
- 综述,总结放疗技术从常规到消融的演变及在胃肠道附近实施消融剂量的实践方面。
主要发现
- 低剂量SBRT 3–5次分割小幅改善中位生存,毒性低、疗程短,但2年及以后无显著差异。
- 使用更长的低分割方案或先进图像引导与自适应计划时,可给予消融剂量(>=100Gy BED)。
- 多项研究显示消融剂量放疗带来令人鼓舞的生存改善。
关键数值与推荐
- 消融剂量定义为>=100Gy BED。
- 低剂量SBRT采用3–5次分割。
临床怎么用
- 采用先进器官运动管理、图像引导(CBCT)和在线自适应MRI引导技术,在胃肠道附近安全实施消融剂量放疗。
局限性
- 原文未报告具体研究样本量、生存数值、毒性数据及P值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Standard doses of conventionally fractionated radiation have had minimal to no impact on the survival duration of patients with locally advanced unresectable pancreatic cancer (LAPC). The use of low-dose stereotactic body radiation (SBRT) in 3- to 5-fractionshas thus far produced a modest improvement in median survival with minimal toxicity and shorter duration of treatment, but failed to produce a meaningful difference at 2 years and beyond. A much higher biologically effective dose (BED) is likely needed to achieve tumor ablation The challenge is the delivery of ablative doses near the very sensitive gastrointestinal tract. Advanced organ motion management, image guidance, and adaptive planning techniques enable delivery of ablative doses of radiation (> = 100Gy BED) when more protracted hypofractionated regimens or advanced image guidance and adaptive planning are used. This approach has resulted in encouraging improvements in survival in several studies. This review will summarize the evolution of the radiation technique over time from conventional to ablative and describe the practical aspects of delivering ablative doses near the GI tract using cone beam CT image (CBCT) guidance and online adaptive MRI guidance.
引用
- Reyngold M, Parikh P, Crane CH, et al. Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results. Radiat Oncol. 2019. PMID: 31171025. doi:10.1186/s13014-019-1309-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。